Epigral Ltd Schedules Conference Call to Discuss Q1 FY27 Results on July 27, 2026
Epigral Limited has announced a conference call scheduled for Monday, July 27, 2026, at 5:00 PM (IST) to discuss the results for the first quarter of fiscal year 2027 (Q1 FY27). The event is being organized by EMKAY GLOBAL FINANCIAL SERVICES LTD.The conference call will feature several senior members from Epigral Ltd. These participants include Maulik Patel, Chairman and Managing Director; Kaushal Soparkar, Executive Director; Rakesh Agrawal, Chief Financial Officer; and Milind Kotecha, who serves as Investor Relations and Strategy for the company.
Scheduled for Monday, July 27, 2026, at 5:00 PM IST, participants interested in attending can use the provided dial-in numbers. Universal access lines are available at +91 22 6280 1325 and +91 22 7115 8226.
A comprehensive list of international toll-free numbers was also provided for attendees, covering regions such as the USA (18667462133), UK (08081011573), Japan (00531161110), and Canada (01180014243444).
EPIGRAL Stock Price Movement
As of 1:44 PM, shares of Epigral Limited are slipping by 1.95% in live trading, currently valued at ₹1141.50 after shedding ₹22.70 from its previous close. The stock has seen significant activity during the session, with a total traded volume reaching 65,846 shares against an intraday range between ₹1124.2 and ₹1173.8.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.